mHealth Technology for HIV
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a new mobile health app, MindBodyU, designed for young people living with HIV in South Carolina. The app helps users stay engaged with their care, take their medication on time, and improve overall well-being. Researchers seek to evaluate the app's ease of use and effectiveness in boosting medication adherence and care engagement. Ideal candidates for this trial are young people diagnosed with HIV who live in South Carolina and speak English. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance healthcare engagement for others.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on using mobile health technology to help with medication adherence, so you might be able to continue your current treatment.
What prior data suggests that this mHealth intervention is safe for youth living with HIV?
Research has shown that mobile health (mHealth) tools like MindBodyU are generally well-received and improve health outcomes for people with HIV. Studies have found that these digital tools assist individuals in taking their medication on time and staying engaged in their care, thereby enhancing adherence to treatment plans. Importantly, past research identified no major safety issues with MindBodyU, suggesting it is safe for users. Most users find these apps helpful and easy to use, with no serious problems reported. This makes mHealth tools like MindBodyU a promising way to enhance health without introducing new risks.12345
Why are researchers excited about this trial?
Unlike traditional treatments for HIV that rely heavily on medication alone, MindBodyU is unique because it leverages mobile health (mHealth) technology to support young people living with HIV in South Carolina. This innovative app not only provides learning content and daily medication reminders but also offers appointment alerts, mental health tracking, and a platform for peer support. Researchers are excited about MindBodyU because it aims to improve medication adherence and psychosocial wellbeing through a holistic, tech-driven approach that engages users actively in their healthcare journey.
What evidence suggests that the MindBodyU intervention is effective for improving care engagement and medication adherence in youth living with HIV?
This trial will evaluate the MindBodyU intervention, a mobile health (mHealth) tool designed to support young people living with HIV. Studies have shown that mHealth tools can effectively assist people with HIV by simplifying medication adherence and maintaining healthcare engagement. Research indicates that mHealth tools, like MindBodyU, can also help young people with HIV manage stigma and access vital resources. For example, some mHealth tools have reduced the amount of virus in the blood, making it less detectable. Overall, these technologies aim to improve health for young people with HIV by facilitating treatment adherence and maintaining connections to care.23567
Are You a Good Fit for This Trial?
This trial is for young people living with HIV in South Carolina who may have trouble staying engaged in care or taking their medication regularly. Participants should be willing to use a mobile health app as part of the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive access to the MindBodyU app, a mobile health intervention designed to improve engagement in care, medication adherence, and psychosocial wellbeing over a 12-week period.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments of engagement/retention in care, adherence to antiretroviral therapy, viral suppression, and psychosocial wellbeing.
What Are the Treatments Tested in This Trial?
Interventions
- MindBodyU Intervention
Trial Overview
The study is testing MindBodyU, a new mobile health (mHealth) app designed to help youth with HIV stay connected to care and take their medications as prescribed. The pilot will last six months and include about 40 participants.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
This is a single group, one arm trial in which participants (youth living with HIV aged 16-25 years who are current residents of South Carolina) will receive access to a mobile health (mHealth) intervention called MindBodyU that is delivered via smartphone application (app) and designed to improve engagement in care, medication adherence, and psychosocial wellbeing. The intervention includes app-based learning content, daily prompts for medication adherence, appointment reminders, behavioral health symptom tracking, ability to connect with content experts, and ability to seek feedback/support from other users. Participants will be instructed to use the intervention over a 12-week period, and will complete surveys at baseline, 12-weeks, and 6-months to assess for feasibility and acceptability of the intervention, as well as participants' engagement/retention in care, adherence to antiretroviral therapy, viral suppression, and psychosocial wellbeing.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Carolina
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
Citations
Scale up mHealth HIV interventions: site and public health ...
A number of mobile health (mHealth) interventions have been shown to be effective and highly acceptable tools for improving human immunodeficiency virus (HIV) ...
Improving the HIV Care Continuum With mHealth Technology
In this study, investigators will conduct a brief pilot trial of the MindBodyU intervention--a digital health intervention that is delivered via ...
3.
scholarspace.manoa.hawaii.edu
scholarspace.manoa.hawaii.edu/items/2c95dd63-d73a-43cd-91e0-6d8e24401ab9Development of MindBodyU—An Innovative mHealth ...
mHealth interventions like MindBodyU may help YLHIV better cope with HIV-related stigma and connect to needed resources. Lessons learned from the development of ...
Effectiveness of an mHealth intervention in HIV/AIDS risk ...
The mHealth intervention is considered effective in enhancing HIV/AIDS risk reduction among LDTs, albeit needing regular updates in the future, as the evidence ...
Improving the HIV Care Continuum With mHealth Technology
Tailored interventions are urgently needed to improve outcomes for this population. One promising approach is to reach YLHIV via mobile Health ( ...
Exploring the equity impact of mobile health-based human ...
While mobile health-based human immunodeficiency virus (HIV) interventions are often designed to promote health equity, systematic differences in the use of ...
Impact of mHealth on enhancing pre-exposure prophylaxis ...
We found that the mHealth intervention significantly contributed to the development of good PrEP adherence among key populations, with statistically significant ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.